Genomic medicines can cost $3 million a dose. How to make them affordable.

The Economist

1 August 2024 - The treatments are marvels of innovation. Their pricing must be inventive, too.

Many diseases are the result of choice or circumstance: an unhealthy way of life, toxic living conditions or a chance encounter with a virus or bacterium. Others are predestined because they are written in the genes.

Read The Economist article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Affordability , Gene therapy